Sharps Technology (NASDAQ: STSS) is a medical device company focused on the development and production of innovative safety syringes. The company's core mission is to reduce the risk of disease transmission caused by needle stab injuries through its technology, protect the safety of medical staff, patients and the public, while improving the accuracy and efficiency of drug delivery. The company has announced the establishment of the SOL treasury.
SkyAI(前身为 Sharps Technology)已出售其财库持有的全部 SOL,持仓量从 9 月份的逾 200 万枚 SOL 降至截至 10 月 16 日的零枚。目前该公司持有 2.238 亿美元现金,并已启动一项回购计划,拟以每股或每份认股权证 3 美元的价格回购至多 2.013 亿美元的资产。
Odaily News - Bastion Trading Limited, a shareholder holding 9.99% of Solana treasury company SkyAI, stated in an SEC filing that it plans to vote against all five current directors at the annual shareholders' meeting on September 18. Bastion expressed deep concerns over the company's amendments to its charter that weaken shareholder rights, the board's implementation of a poison pill without shareholder vote, and related-party transactions. Independent director Annemarie Tierney resigned in December 2025, having previously raised issues regarding potential conflicts of interest and related-party transactions with management. SkyAI, formerly Sharps Technology, established its Solana treasury in August 2025 through a PIPE financing round raising over $400 million. The company currently holds approximately 2 million SOL, with a current market value of around $59 million. Its stock price has declined approximately 86% over the past year.
Odaily News Nasdaq-listed Solana treasury company Sharps Technology officially announced its rebranding to SkyAI, with its stock ticker changing from STSS to SKYA on May 28. The company will build an AI agent financial platform based on the Solana blockchain, offering diversified services such as USD savings, financial education, and asset management to users in emerging markets. (Globenewswire)